Acumen Pharmaceuticals
ABOS0.21637.72% ( -0.0181 )
Acumen Pharmaceuticals (ABOS)
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer’s disease. It focuses on ad...
- Open
- 0.2300
- High
- 0.2496
- Low
- 0.2163
- Prev. Close
- 0.2344
- Volume
- 8.68M
- Turnover
- 2.00M
- Avg Price
- 0.2305
- Bid/Ask Ratio
- 0.00%
- Amplitude
- 14.21%
- 52wk High
- 3.6000
- Volume Ratio
- 39.05
- Turnover Ratio
- 23.42%
- 52wk Low
- 0.1980
- Float Mkt Cap
- 8.02M
- Market CapUSD
- 15.64M
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -1.44
- EPSDynamic
- -1.40
- EPSStatic
- --
- BVPS
- 0.48
- P/B
- 0.45
- Circulating Supply
- 37.06M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 72.33M
- Min lot size
- 1
- Currency
- USD
Acumen Pharmaceuticals Analyst Rating
View moreForecast & Rating
Nov 2, 2026Price forecast
$1.00362.32%
Forecast & RatingHold
6analysts
- Strong buy16.67%
- Buy0.00%
- Hold50.00%
- Sell16.67%
- Strong sell16.67%
News
- benzinga_article ·
12 Health Care Stocks Moving In Monday's Pre-Market Session
- benzinga_article ·
12 Health Care Stocks Moving In Monday's Intraday Session
- Market Movers ·
Acumen Pharmaceuticals surges 16%
- benzinga_article ·
Regeneron Pharmaceuticals To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Monday
- Market Movers ·
Acumen Pharmaceuticals 盘前创 52 周新低，现报 $0.21。
- TradingView ·
BTIG maintains Acumen Pharmaceuticals at Buy, lowers price target to $1 from $8
